1. Home
  2. APRE vs MARPS Comparison

APRE vs MARPS Comparison

Compare APRE & MARPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • MARPS
  • Stock Information
  • Founded
  • APRE 2006
  • MARPS 1956
  • Country
  • APRE United States
  • MARPS United States
  • Employees
  • APRE N/A
  • MARPS N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • MARPS Oil & Gas Production
  • Sector
  • APRE Health Care
  • MARPS Energy
  • Exchange
  • APRE Nasdaq
  • MARPS Nasdaq
  • Market Cap
  • APRE 9.4M
  • MARPS 8.6M
  • IPO Year
  • APRE 2019
  • MARPS N/A
  • Fundamental
  • Price
  • APRE $1.55
  • MARPS $4.60
  • Analyst Decision
  • APRE Strong Buy
  • MARPS
  • Analyst Count
  • APRE 1
  • MARPS 0
  • Target Price
  • APRE $20.00
  • MARPS N/A
  • AVG Volume (30 Days)
  • APRE 33.0K
  • MARPS 6.7K
  • Earning Date
  • APRE 11-06-2025
  • MARPS 01-01-0001
  • Dividend Yield
  • APRE N/A
  • MARPS 7.81%
  • EPS Growth
  • APRE N/A
  • MARPS N/A
  • EPS
  • APRE N/A
  • MARPS 0.36
  • Revenue
  • APRE $841,012.00
  • MARPS $1,036,019.00
  • Revenue This Year
  • APRE N/A
  • MARPS N/A
  • Revenue Next Year
  • APRE N/A
  • MARPS N/A
  • P/E Ratio
  • APRE N/A
  • MARPS $12.65
  • Revenue Growth
  • APRE N/A
  • MARPS N/A
  • 52 Week Low
  • APRE $1.41
  • MARPS $3.34
  • 52 Week High
  • APRE $5.01
  • MARPS $7.90
  • Technical
  • Relative Strength Index (RSI)
  • APRE 42.03
  • MARPS 49.07
  • Support Level
  • APRE $1.49
  • MARPS $4.59
  • Resistance Level
  • APRE $1.65
  • MARPS $5.04
  • Average True Range (ATR)
  • APRE 0.08
  • MARPS 0.20
  • MACD
  • APRE -0.01
  • MARPS 0.01
  • Stochastic Oscillator
  • APRE 23.08
  • MARPS 46.51

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About MARPS Marine Petroleum Trust Units of Beneficial Interest

Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.

Share on Social Networks: